The global Mesenchymal Stem Cells market was valued at US$ 1389 million in 2025 and is anticipated to reach US$ 2785 million by 2032, at a CAGR of 10.6% from 2026 to 2032.

Mesenchymal Stem Cells Market

Mesenchymal Stem Cells (MSCs) are multipotent stem cells derived from various tissues such as bone marrow, umbilical cord, adipose tissue, and placenta. They possess strong self-renewal and multilineage differentiation capabilities, enabling them to differentiate into osteoblasts, chondrocytes, adipocytes, and other mesenchymal-origin cells. MSCs are characterized by low immunogenicity, immunomodulatory effects, and robust cytokine secretion, making them a key focus in regenerative medicine, immune therapy, and anti-inflammatory treatment. With advancements in cell culture techniques, serum-free media, and GMP-compliant manufacturing, MSCs are transitioning from preclinical research to clinical applications, finding broad use in orthopedic disorders, cardiovascular diseases, autoimmune conditions, oncology, and tissue engineering. The MSC industry spans upstream cell sourcing, large-scale expansion, cryopreservation, logistics, and therapeutic product development, positioning MSCs as a cornerstone of the global cell and gene therapy (CGT) market and a critical driver of precision medicine, drawing strong attention from investors and regulatory authorities worldwide.

The mesenchymal stem cell (MSC) industry is entering a phase of accelerated growth, driven by the global boom in cell and gene therapy R&D, rising healthcare needs of aging populations, and supportive regenerative medicine policies. According to public annual reports, the number of ongoing MSC clinical trials continues to grow, with over 300 trials registered in the U.S. and China in 2024 alone, covering neurological, metabolic, and autoimmune disorders. Governments are investing heavily in innovation, supporting GMP-compliant manufacturing facilities and quality standardization, reducing technical barriers. Frequent collaborations between multinational pharmaceutical companies and regional CDMOs are facilitating industrial-scale production and rapid market penetration. With increasing investments from Asia and the Middle East, MSCs are poised to become a strategic focus in global precision and personalized medicine development.

Despite rapid growth, the MSC industry faces challenges such as complex cell sourcing, difficulties in large-scale manufacturing, inconsistent clinical protocols, and varying regulatory requirements across regions. Many companies lack mature experience in process optimization and batch consistency, resulting in high costs and extended commercialization timelines. Intellectual property barriers, cross-border clinical certifications, and global regulatory complexities further increase entry thresholds, particularly for small and mid-sized players. Market uncertainties, including fluctuations in capital markets and healthcare reimbursement policies, also pose risks. Balancing strict quality standards, cost efficiency, and accessible pricing will be critical for shaping the competitive landscape.

Demand is rapidly shifting from basic research to commercial clinical applications. The growth of immunotherapy, tissue engineering, and personalized medicine is expanding MSC use cases, including cardiovascular repair, cartilage regeneration, autoimmune disease management, anti-aging therapies, and medical aesthetics. Emerging integration with mRNA technology and gene editing is creating vast opportunities for premium, customized MSC products. Companies and research institutions are accelerating automation and digital process control to enhance product consistency and reduce costs. The convergence of aging demographics, chronic disease prevalence, and supportive policy frameworks positions MSCs as a central growth engine in the global cell therapy market over the next five years.

This report delivers a comprehensive overview of the global Mesenchymal Stem Cells market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Mesenchymal Stem Cells. The Mesenchymal Stem Cells market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Mesenchymal Stem Cells market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Mesenchymal Stem Cells manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Mesenchymal Stem Cells Market Report

Report Metric	Details
Report Name	Mesenchymal Stem Cells Market
Accounted market size in 2025	US$ 1389 million
Forecasted market size in 2032	US$ 2785 million
CAGR	10.6%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Umbilical Cord Derived MSC Bone Marrow Derived MSC Placenta Derived MSC Other
Segment by Application	Research Disease Treatment Beauty and Anti-aging Storage
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	CellResearch, StemCord, Cytopeutics, CryoCord, Cell Malaysia, Bangkok Stem Cell, Vinmec Stem Cell Institute, ProSTEM, Cryoviva, StemCells21, Lonza, Thermo Fisher Scientific, PromoCell, Stemcell Technologies, Bio-Techne, ATCC, Merck
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Mesenchymal Stem Cells companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Mesenchymal Stem Cells Market growing?

Ans: The Mesenchymal Stem Cells Market witnessing a CAGR of 10.6% during the forecast period 2026-2032.

What is the Mesenchymal Stem Cells Market size in 2032?

Ans: The Mesenchymal Stem Cells Market size in 2032 will be US$ 2785 million.

Who are the main players in the Mesenchymal Stem Cells Market report?

Ans: The main players in the Mesenchymal Stem Cells Market are CellResearch, StemCord, Cytopeutics, CryoCord, Cell Malaysia, Bangkok Stem Cell, Vinmec Stem Cell Institute, ProSTEM, Cryoviva, StemCells21, Lonza, Thermo Fisher Scientific, PromoCell, Stemcell Technologies, Bio-Techne, ATCC, Merck

What are the Application segmentation covered in the Mesenchymal Stem Cells Market report?

Ans: The Applications covered in the Mesenchymal Stem Cells Market report are Research, Disease Treatment, Beauty and Anti-aging, Storage

What are the Type segmentation covered in the Mesenchymal Stem Cells Market report?

Ans: The Types covered in the Mesenchymal Stem Cells Market report are Umbilical Cord Derived MSC, Bone Marrow Derived MSC, Placenta Derived MSC, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Mesenchymal Stem Cells Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Umbilical Cord Derived MSC

1.2.3 Bone Marrow Derived MSC

1.2.4 Placenta Derived MSC

1.2.5 Other

1.3 Market by Application

1.3.1 Global Mesenchymal Stem Cells Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Research

1.3.3 Disease Treatment

1.3.4 Beauty and Anti-aging

1.3.5 Storage

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Mesenchymal Stem Cells Market Perspective (2021–2032)

2.2 Global Mesenchymal Stem Cells Growth Trends by Region

2.2.1 Global Mesenchymal Stem Cells Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Mesenchymal Stem Cells Historic Market Size by Region (2021–2026)

2.2.3 Mesenchymal Stem Cells Forecasted Market Size by Region (2027–2032)

2.3 Mesenchymal Stem Cells Market Dynamics

2.3.1 Mesenchymal Stem Cells Industry Trends

2.3.2 Mesenchymal Stem Cells Market Drivers

2.3.3 Mesenchymal Stem Cells Market Challenges

2.3.4 Mesenchymal Stem Cells Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Mesenchymal Stem Cells Players by Revenue

3.1.1 Global Top Mesenchymal Stem Cells Players by Revenue (2021–2026)

3.1.2 Global Mesenchymal Stem Cells Revenue Market Share by Players (2021–2026)

3.2 Global Top Mesenchymal Stem Cells Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Mesenchymal Stem Cells Revenue

3.4 Global Mesenchymal Stem Cells Market Concentration Ratio

3.4.1 Global Mesenchymal Stem Cells Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Mesenchymal Stem Cells Revenue in 2025

3.5 Global Key Players of Mesenchymal Stem Cells Head Offices and Areas Served

3.6 Global Key Players of Mesenchymal Stem Cells, Products and Applications

3.7 Global Key Players of Mesenchymal Stem Cells, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Mesenchymal Stem Cells Breakdown Data by Type

4.1 Global Mesenchymal Stem Cells Historic Market Size by Type (2021–2026)

4.2 Global Mesenchymal Stem Cells Forecasted Market Size by Type (2027–2032)

5 Mesenchymal Stem Cells Breakdown Data by Application

5.1 Global Mesenchymal Stem Cells Historic Market Size by Application (2021–2026)

5.2 Global Mesenchymal Stem Cells Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Mesenchymal Stem Cells Market Size (2021–2032)

6.2 North America Mesenchymal Stem Cells Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Mesenchymal Stem Cells Market Size by Country (2021–2026)

6.4 North America Mesenchymal Stem Cells Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Mesenchymal Stem Cells Market Size (2021–2032)

7.2 Europe Mesenchymal Stem Cells Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Mesenchymal Stem Cells Market Size by Country (2021–2026)

7.4 Europe Mesenchymal Stem Cells Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Mesenchymal Stem Cells Market Size (2021–2032)

8.2 Asia-Pacific Mesenchymal Stem Cells Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Mesenchymal Stem Cells Market Size by Region (2021–2026)

8.4 Asia-Pacific Mesenchymal Stem Cells Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Mesenchymal Stem Cells Market Size (2021–2032)

9.2 Latin America Mesenchymal Stem Cells Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Mesenchymal Stem Cells Market Size by Country (2021–2026)

9.4 Latin America Mesenchymal Stem Cells Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Mesenchymal Stem Cells Market Size (2021–2032)

10.2 Middle East & Africa Mesenchymal Stem Cells Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Mesenchymal Stem Cells Market Size by Country (2021–2026)

10.4 Middle East & Africa Mesenchymal Stem Cells Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 CellResearch

11.1.1 CellResearch Company Details

11.1.2 CellResearch Business Overview

11.1.3 CellResearch Mesenchymal Stem Cells Introduction

11.1.4 CellResearch Revenue in Mesenchymal Stem Cells Business (2021–2026)

11.1.5 CellResearch Recent Development

11.2 StemCord

11.2.1 StemCord Company Details

11.2.2 StemCord Business Overview

11.2.3 StemCord Mesenchymal Stem Cells Introduction

11.2.4 StemCord Revenue in Mesenchymal Stem Cells Business (2021–2026)

11.2.5 StemCord Recent Development

11.3 Cytopeutics

11.3.1 Cytopeutics Company Details

11.3.2 Cytopeutics Business Overview

11.3.3 Cytopeutics Mesenchymal Stem Cells Introduction

11.3.4 Cytopeutics Revenue in Mesenchymal Stem Cells Business (2021–2026)

11.3.5 Cytopeutics Recent Development

11.4 CryoCord

11.4.1 CryoCord Company Details

11.4.2 CryoCord Business Overview

11.4.3 CryoCord Mesenchymal Stem Cells Introduction

11.4.4 CryoCord Revenue in Mesenchymal Stem Cells Business (2021–2026)

11.4.5 CryoCord Recent Development

11.5 Cell Malaysia

11.5.1 Cell Malaysia Company Details

11.5.2 Cell Malaysia Business Overview

11.5.3 Cell Malaysia Mesenchymal Stem Cells Introduction

11.5.4 Cell Malaysia Revenue in Mesenchymal Stem Cells Business (2021–2026)

11.5.5 Cell Malaysia Recent Development

11.6 Bangkok Stem Cell

11.6.1 Bangkok Stem Cell Company Details

11.6.2 Bangkok Stem Cell Business Overview

11.6.3 Bangkok Stem Cell Mesenchymal Stem Cells Introduction

11.6.4 Bangkok Stem Cell Revenue in Mesenchymal Stem Cells Business (2021–2026)

11.6.5 Bangkok Stem Cell Recent Development

11.7 Vinmec Stem Cell Institute

11.7.1 Vinmec Stem Cell Institute Company Details

11.7.2 Vinmec Stem Cell Institute Business Overview

11.7.3 Vinmec Stem Cell Institute Mesenchymal Stem Cells Introduction

11.7.4 Vinmec Stem Cell Institute Revenue in Mesenchymal Stem Cells Business (2021–2026)

11.7.5 Vinmec Stem Cell Institute Recent Development

11.8 ProSTEM

11.8.1 ProSTEM Company Details

11.8.2 ProSTEM Business Overview

11.8.3 ProSTEM Mesenchymal Stem Cells Introduction

11.8.4 ProSTEM Revenue in Mesenchymal Stem Cells Business (2021–2026)

11.8.5 ProSTEM Recent Development

11.9 Cryoviva

11.9.1 Cryoviva Company Details

11.9.2 Cryoviva Business Overview

11.9.3 Cryoviva Mesenchymal Stem Cells Introduction

11.9.4 Cryoviva Revenue in Mesenchymal Stem Cells Business (2021–2026)

11.9.5 Cryoviva Recent Development

11.10 StemCells21

11.10.1 StemCells21 Company Details

11.10.2 StemCells21 Business Overview

11.10.3 StemCells21 Mesenchymal Stem Cells Introduction

11.10.4 StemCells21 Revenue in Mesenchymal Stem Cells Business (2021–2026)

11.10.5 StemCells21 Recent Development

11.11 Lonza

11.11.1 Lonza Company Details

11.11.2 Lonza Business Overview

11.11.3 Lonza Mesenchymal Stem Cells Introduction

11.11.4 Lonza Revenue in Mesenchymal Stem Cells Business (2021–2026)

11.11.5 Lonza Recent Development

11.12 Thermo Fisher Scientific

11.12.1 Thermo Fisher Scientific Company Details

11.12.2 Thermo Fisher Scientific Business Overview

11.12.3 Thermo Fisher Scientific Mesenchymal Stem Cells Introduction

11.12.4 Thermo Fisher Scientific Revenue in Mesenchymal Stem Cells Business (2021–2026)

11.12.5 Thermo Fisher Scientific Recent Development

11.13 PromoCell

11.13.1 PromoCell Company Details

11.13.2 PromoCell Business Overview

11.13.3 PromoCell Mesenchymal Stem Cells Introduction

11.13.4 PromoCell Revenue in Mesenchymal Stem Cells Business (2021–2026)

11.13.5 PromoCell Recent Development

11.14 Stemcell Technologies

11.14.1 Stemcell Technologies Company Details

11.14.2 Stemcell Technologies Business Overview

11.14.3 Stemcell Technologies Mesenchymal Stem Cells Introduction

11.14.4 Stemcell Technologies Revenue in Mesenchymal Stem Cells Business (2021–2026)

11.14.5 Stemcell Technologies Recent Development

11.15 Bio-Techne

11.15.1 Bio-Techne Company Details

11.15.2 Bio-Techne Business Overview

11.15.3 Bio-Techne Mesenchymal Stem Cells Introduction

11.15.4 Bio-Techne Revenue in Mesenchymal Stem Cells Business (2021–2026)

11.15.5 Bio-Techne Recent Development

11.16 ATCC

11.16.1 ATCC Company Details

11.16.2 ATCC Business Overview

11.16.3 ATCC Mesenchymal Stem Cells Introduction

11.16.4 ATCC Revenue in Mesenchymal Stem Cells Business (2021–2026)

11.16.5 ATCC Recent Development

11.17 Merck

11.17.1 Merck Company Details

11.17.2 Merck Business Overview

11.17.3 Merck Mesenchymal Stem Cells Introduction

11.17.4 Merck Revenue in Mesenchymal Stem Cells Business (2021–2026)

11.17.5 Merck Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Lonza

Bio-Techne

ATCC

PromoCell

Thermo Fisher Scientific

StemCell Technologies

Merck

Cell Malaysia

Bangkok Stem Cell

Vinmec Stem Cell Institute

ProSTEM

List of Tables

Table 1. Global Mesenchymal Stem Cells Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Umbilical Cord Derived MSC

Table 3. Key Players of Bone Marrow Derived MSC

Table 4. Key Players of Placenta Derived MSC

Table 5. Key Players of Other

Table 6. Global Mesenchymal Stem Cells Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 7. Global Mesenchymal Stem Cells Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 8. Global Mesenchymal Stem Cells Market Size by Region (US$ Million), 2021–2026

Table 9. Global Mesenchymal Stem Cells Market Share by Region (2021–2026)

Table 10. Global Mesenchymal Stem Cells Forecasted Market Size by Region (US$ Million), 2027–2032

Table 11. Global Mesenchymal Stem Cells Market Share by Region (2027–2032)

Table 12. Mesenchymal Stem Cells Market Trends

Table 13. Mesenchymal Stem Cells Market Drivers

Table 14. Mesenchymal Stem Cells Market Challenges

Table 15. Mesenchymal Stem Cells Market Restraints

Table 16. Global Mesenchymal Stem Cells Revenue by Players (US$ Million), 2021–2026

Table 17. Global Mesenchymal Stem Cells Market Share by Players (2021–2026)

Table 18. Global Top Mesenchymal Stem Cells Players by Tier (Tier 1, Tier 2, and Tier 3), based on Mesenchymal Stem Cells Revenue, 2025

Table 19. Ranking of Global Top Mesenchymal Stem Cells Companies by Revenue (US$ Million) in 2025

Table 20. Global 5 Largest Players Market Share by Mesenchymal Stem Cells Revenue (CR5 and HHI), 2021–2026

Table 21. Global Key Players of Mesenchymal Stem Cells, Headquarters and Area Served

Table 22. Global Key Players of Mesenchymal Stem Cells, Products and Applications

Table 23. Global Key Players of Mesenchymal Stem Cells, Date of General Availability (GA)

Table 24. Mergers and Acquisitions, Expansion Plans

Table 25. Global Mesenchymal Stem Cells Market Size by Type (US$ Million), 2021–2026

Table 26. Global Mesenchymal Stem Cells Revenue Market Share by Type (2021–2026)

Table 27. Global Mesenchymal Stem Cells Forecasted Market Size by Type (US$ Million), 2027–2032

Table 28. Global Mesenchymal Stem Cells Revenue Market Share by Type (2027–2032)

Table 29. Global Mesenchymal Stem Cells Market Size by Application (US$ Million), 2021–2026

Table 30. Global Mesenchymal Stem Cells Revenue Market Share by Application (2021–2026)

Table 31. Global Mesenchymal Stem Cells Forecasted Market Size by Application (US$ Million), 2027–2032

Table 32. Global Mesenchymal Stem Cells Revenue Market Share by Application (2027–2032)

Table 33. North America Mesenchymal Stem Cells Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 34. North America Mesenchymal Stem Cells Market Size by Country (US$ Million), 2021–2026

Table 35. North America Mesenchymal Stem Cells Market Size by Country (US$ Million), 2027–2032

Table 36. Europe Mesenchymal Stem Cells Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 37. Europe Mesenchymal Stem Cells Market Size by Country (US$ Million), 2021–2026

Table 38. Europe Mesenchymal Stem Cells Market Size by Country (US$ Million), 2027–2032

Table 39. Asia-Pacific Mesenchymal Stem Cells Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 40. Asia-Pacific Mesenchymal Stem Cells Market Size by Region (US$ Million), 2021–2026

Table 41. Asia-Pacific Mesenchymal Stem Cells Market Size by Region (US$ Million), 2027–2032

Table 42. Latin America Mesenchymal Stem Cells Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 43. Latin America Mesenchymal Stem Cells Market Size by Country (US$ Million), 2021–2026

Table 44. Latin America Mesenchymal Stem Cells Market Size by Country (US$ Million), 2027–2032

Table 45. Middle East & Africa Mesenchymal Stem Cells Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 46. Middle East & Africa Mesenchymal Stem Cells Market Size by Country (US$ Million), 2021–2026

Table 47. Middle East & Africa Mesenchymal Stem Cells Market Size by Country (US$ Million), 2027–2032

Table 48. CellResearch Company Details

Table 49. CellResearch Business Overview

Table 50. CellResearch Mesenchymal Stem Cells Product

Table 51. CellResearch Revenue in Mesenchymal Stem Cells Business (US$ Million), 2021–2026

Table 52. CellResearch Recent Development

Table 53. StemCord Company Details

Table 54. StemCord Business Overview

Table 55. StemCord Mesenchymal Stem Cells Product

Table 56. StemCord Revenue in Mesenchymal Stem Cells Business (US$ Million), 2021–2026

Table 57. StemCord Recent Development

Table 58. Cytopeutics Company Details

Table 59. Cytopeutics Business Overview

Table 60. Cytopeutics Mesenchymal Stem Cells Product

Table 61. Cytopeutics Revenue in Mesenchymal Stem Cells Business (US$ Million), 2021–2026

Table 62. Cytopeutics Recent Development

Table 63. CryoCord Company Details

Table 64. CryoCord Business Overview

Table 65. CryoCord Mesenchymal Stem Cells Product

Table 66. CryoCord Revenue in Mesenchymal Stem Cells Business (US$ Million), 2021–2026

Table 67. CryoCord Recent Development

Table 68. Cell Malaysia Company Details

Table 69. Cell Malaysia Business Overview

Table 70. Cell Malaysia Mesenchymal Stem Cells Product

Table 71. Cell Malaysia Revenue in Mesenchymal Stem Cells Business (US$ Million), 2021–2026

Table 72. Cell Malaysia Recent Development

Table 73. Bangkok Stem Cell Company Details

Table 74. Bangkok Stem Cell Business Overview

Table 75. Bangkok Stem Cell Mesenchymal Stem Cells Product

Table 76. Bangkok Stem Cell Revenue in Mesenchymal Stem Cells Business (US$ Million), 2021–2026

Table 77. Bangkok Stem Cell Recent Development

Table 78. Vinmec Stem Cell Institute Company Details

Table 79. Vinmec Stem Cell Institute Business Overview

Table 80. Vinmec Stem Cell Institute Mesenchymal Stem Cells Product

Table 81. Vinmec Stem Cell Institute Revenue in Mesenchymal Stem Cells Business (US$ Million), 2021–2026

Table 82. Vinmec Stem Cell Institute Recent Development

Table 83. ProSTEM Company Details

Table 84. ProSTEM Business Overview

Table 85. ProSTEM Mesenchymal Stem Cells Product

Table 86. ProSTEM Revenue in Mesenchymal Stem Cells Business (US$ Million), 2021–2026

Table 87. ProSTEM Recent Development

Table 88. Cryoviva Company Details

Table 89. Cryoviva Business Overview

Table 90. Cryoviva Mesenchymal Stem Cells Product

Table 91. Cryoviva Revenue in Mesenchymal Stem Cells Business (US$ Million), 2021–2026

Table 92. Cryoviva Recent Development

Table 93. StemCells21 Company Details

Table 94. StemCells21 Business Overview

Table 95. StemCells21 Mesenchymal Stem Cells Product

Table 96. StemCells21 Revenue in Mesenchymal Stem Cells Business (US$ Million), 2021–2026

Table 97. StemCells21 Recent Development

Table 98. Lonza Company Details

Table 99. Lonza Business Overview

Table 100. Lonza Mesenchymal Stem Cells Product

Table 101. Lonza Revenue in Mesenchymal Stem Cells Business (US$ Million), 2021–2026

Table 102. Lonza Recent Development

Table 103. Thermo Fisher Scientific Company Details

Table 104. Thermo Fisher Scientific Business Overview

Table 105. Thermo Fisher Scientific Mesenchymal Stem Cells Product

Table 106. Thermo Fisher Scientific Revenue in Mesenchymal Stem Cells Business (US$ Million), 2021–2026

Table 107. Thermo Fisher Scientific Recent Development

Table 108. PromoCell Company Details

Table 109. PromoCell Business Overview

Table 110. PromoCell Mesenchymal Stem Cells Product

Table 111. PromoCell Revenue in Mesenchymal Stem Cells Business (US$ Million), 2021–2026

Table 112. PromoCell Recent Development

Table 113. Stemcell Technologies Company Details

Table 114. Stemcell Technologies Business Overview

Table 115. Stemcell Technologies Mesenchymal Stem Cells Product

Table 116. Stemcell Technologies Revenue in Mesenchymal Stem Cells Business (US$ Million), 2021–2026

Table 117. Stemcell Technologies Recent Development

Table 118. Bio-Techne Company Details

Table 119. Bio-Techne Business Overview

Table 120. Bio-Techne Mesenchymal Stem Cells Product

Table 121. Bio-Techne Revenue in Mesenchymal Stem Cells Business (US$ Million), 2021–2026

Table 122. Bio-Techne Recent Development

Table 123. ATCC Company Details

Table 124. ATCC Business Overview

Table 125. ATCC Mesenchymal Stem Cells Product

Table 126. ATCC Revenue in Mesenchymal Stem Cells Business (US$ Million), 2021–2026

Table 127. ATCC Recent Development

Table 128. Merck Company Details

Table 129. Merck Business Overview

Table 130. Merck Mesenchymal Stem Cells Product

Table 131. Merck Revenue in Mesenchymal Stem Cells Business (US$ Million), 2021–2026

Table 132. Merck Recent Development

Table 133. Research Programs/Design for This Report

Table 134. Key Data Information from Secondary Sources

Table 135. Key Data Information from Primary Sources

Table 136. Authors List of This Report

List of Figures

Figure 1. Mesenchymal Stem Cells Picture

Figure 2. Global Mesenchymal Stem Cells Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Mesenchymal Stem Cells Market Share by Type: 2025 vs 2032

Figure 4. Umbilical Cord Derived MSC Features

Figure 5. Bone Marrow Derived MSC Features

Figure 6. Placenta Derived MSC Features

Figure 7. Other Features

Figure 8. Global Mesenchymal Stem Cells Market Size by Application (US$ Million), 2021–2032

Figure 9. Global Mesenchymal Stem Cells Market Share by Application: 2025 vs 2032

Figure 10. Research Case Studies

Figure 11. Disease Treatment Case Studies

Figure 12. Beauty and Anti-aging Case Studies

Figure 13. Storage Case Studies

Figure 14. Mesenchymal Stem Cells Report Years Considered

Figure 15. Global Mesenchymal Stem Cells Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 16. Global Mesenchymal Stem Cells Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 17. Global Mesenchymal Stem Cells Market Share by Region: 2025 vs 2032

Figure 18. Global Mesenchymal Stem Cells Market Share by Players in 2025

Figure 19. Global Mesenchymal Stem Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 20. The Top 10 and 5 Players Market Share by Mesenchymal Stem Cells Revenue in 2025

Figure 21. North America Mesenchymal Stem Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 22. North America Mesenchymal Stem Cells Market Share by Country (2021–2032)

Figure 23. United States Mesenchymal Stem Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. Canada Mesenchymal Stem Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. Europe Mesenchymal Stem Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. Europe Mesenchymal Stem Cells Market Share by Country (2021–2032)

Figure 27. Germany Mesenchymal Stem Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. France Mesenchymal Stem Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. U.K. Mesenchymal Stem Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Italy Mesenchymal Stem Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Russia Mesenchymal Stem Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Ireland Mesenchymal Stem Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Asia-Pacific Mesenchymal Stem Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Asia-Pacific Mesenchymal Stem Cells Market Share by Region (2021–2032)

Figure 35. China Mesenchymal Stem Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Japan Mesenchymal Stem Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. South Korea Mesenchymal Stem Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Southeast Asia Mesenchymal Stem Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. India Mesenchymal Stem Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Australia & New Zealand Mesenchymal Stem Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Latin America Mesenchymal Stem Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Latin America Mesenchymal Stem Cells Market Share by Country (2021–2032)

Figure 43. Mexico Mesenchymal Stem Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Brazil Mesenchymal Stem Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Middle East & Africa Mesenchymal Stem Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Middle East & Africa Mesenchymal Stem Cells Market Share by Country (2021–2032)

Figure 47. Israel Mesenchymal Stem Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Saudi Arabia Mesenchymal Stem Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. UAE Mesenchymal Stem Cells Market Size YoY Growth (US$ Million), 2021–2032

Figure 50. CellResearch Revenue Growth Rate in Mesenchymal Stem Cells Business (2021–2026)

Figure 51. StemCord Revenue Growth Rate in Mesenchymal Stem Cells Business (2021–2026)

Figure 52. Cytopeutics Revenue Growth Rate in Mesenchymal Stem Cells Business (2021–2026)

Figure 53. CryoCord Revenue Growth Rate in Mesenchymal Stem Cells Business (2021–2026)

Figure 54. Cell Malaysia Revenue Growth Rate in Mesenchymal Stem Cells Business (2021–2026)

Figure 55. Bangkok Stem Cell Revenue Growth Rate in Mesenchymal Stem Cells Business (2021–2026)

Figure 56. Vinmec Stem Cell Institute Revenue Growth Rate in Mesenchymal Stem Cells Business (2021–2026)

Figure 57. ProSTEM Revenue Growth Rate in Mesenchymal Stem Cells Business (2021–2026)

Figure 58. Cryoviva Revenue Growth Rate in Mesenchymal Stem Cells Business (2021–2026)

Figure 59. StemCells21 Revenue Growth Rate in Mesenchymal Stem Cells Business (2021–2026)

Figure 60. Lonza Revenue Growth Rate in Mesenchymal Stem Cells Business (2021–2026)

Figure 61. Thermo Fisher Scientific Revenue Growth Rate in Mesenchymal Stem Cells Business (2021–2026)

Figure 62. PromoCell Revenue Growth Rate in Mesenchymal Stem Cells Business (2021–2026)

Figure 63. Stemcell Technologies Revenue Growth Rate in Mesenchymal Stem Cells Business (2021–2026)

Figure 64. Bio-Techne Revenue Growth Rate in Mesenchymal Stem Cells Business (2021–2026)

Figure 65. ATCC Revenue Growth Rate in Mesenchymal Stem Cells Business (2021–2026)

Figure 66. Merck Revenue Growth Rate in Mesenchymal Stem Cells Business (2021–2026)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Mesenchymal Stem Cell Injection Market Research Report 2024

Global Human Mesenchymal Stem Cells hMSC Market Insights Forecast to 2030

Stem Cells Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Adipose Tissue Derived Stem Cell Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Mesenchymal Stem Cell Therapy MSCT Market Research Report 2025

Global Mesenchymal Stem Cell MSC Medium Market Research Report 2025

Global Stem Cell Research Antibodies Market Research Report 2024

Global Adipose Derived Stem Cell Therapy Market Research Report 2024

Global Adipose Tissue derived Stem Cell Therapy Market Research Report 2024

Global Neural Stem Cell Media Market Research Report 2024

Global Stem Cell and Primary Cell Culture Medium Market Insights Forecast to 2030

Progenitor Cell Product Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Human Embryonic Stem Cells HESC Market Research Report 2024

Global Stem Cell Services Market Insights Forecast to 2030

Global Mesenchymal Stem Cell Medium Market Research Report 2025

Global Neural Stem Cell Media and Reagents Market Research Report 2024

Global Mesenchymal Stem Cell Media Market Research Report 2024

Placental Stem Cell Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Mesenchymal Stem Cell MSCs Therapeutic Product CDMO Service Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions